|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1992-10-13
|
|
pubmed:abstractText |
To determine the effectiveness of the combination therapy with daytime chlorpropamide-metformin and bedtime NPH insulin in the treatment of secondary failures in NIDDM and to study its effects on insulin secretion.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0034-8376
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
71-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1523352-Adult,
pubmed-meshheading:1523352-Aged,
pubmed-meshheading:1523352-Chlorpropamide,
pubmed-meshheading:1523352-Diabetes Mellitus, Type 2,
pubmed-meshheading:1523352-Drug Administration Schedule,
pubmed-meshheading:1523352-Drug Therapy, Combination,
pubmed-meshheading:1523352-Female,
pubmed-meshheading:1523352-Humans,
pubmed-meshheading:1523352-Insulin,
pubmed-meshheading:1523352-Male,
pubmed-meshheading:1523352-Metformin,
pubmed-meshheading:1523352-Middle Aged
|
|
pubmed:articleTitle |
Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
|
|
pubmed:affiliation |
Departamento de Diabetes y Metabolismo de Lipidos, Instituto Nacional de la Nutrición Salvador Zubirán, México, D.F.
|
|
pubmed:publicationType |
Journal Article
|
